Stockreport

VolitionRX Ltd (VNRX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... [Yahoo! Finance]

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com
PDF Year-to-Date Revenue: Approximately $730,000 from veterinary kits and key components. Third Quarter Revenue: $475,000, a growth of 187% year-on-year. Total Revenue [Read more]